Elsevier

Schizophrenia Research

Volume 1, Issue 1, January–February 1988, Pages 31-35
Schizophrenia Research

Fluphenazine decanoate dose and severity of depression in patients with post-psychotic depression

https://doi.org/10.1016/0920-9964(88)90037-0Get rights and content

Abstract

The authors examined the fluphenazine decanoate dose and the fluphenazine plasma levels in comparison with measures of severity of depression in schizophrenic and schizoaffective patients. All patients were selected for study on the basis of having stable, syndromally defined, antiparkinsonian non-responsive syndromes of post-psychotic depression. No meaningful relationships were found. The implications of this observation with regard to the notion that depressive symptomatology in such patients is neuroleptic-induced is discussed.

References (47)

  • A. Roy

    Do neuroleptics cause depression?

    Biol. Psychiatry

    (1984)
  • J. Ananth et al.

    Drug induced mood disorder

    Int. Pharmacopsychiatry

    (1980)
  • W.E. Bunney

    Psychopharmacology of the switch process in affective disorders

  • M.W.P. Carney et al.

    Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia

    Br. J. Psychiatry

    (1975)
  • R. DeAlarcon et al.

    Severe depressive mood changes following slow-release intramuscular fluphenazine injection

    Br. Med. J.

    (1969)
  • S.J. Dencker et al.

    A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes

    Acta Psychiatr. Scand.

    (1973)
  • P.T. Donlon et al.

    Depression and reintegration phase of acute schizophrenia

    Am. J. Psychiatry

    (1976)
  • J. Endicott et al.

    A diagnostic interview: The schedule for affective disorders and schizophrenia

    Arch. Gen. Psychiatry

    (1978)
  • J. Endicott et al.

    Hamilton Depression Rating Scale: Extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia

    Arch. Gen. Psychiatry

    (1981)
  • I. Faloon et al.

    A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia

    Psychol. Med.

    (1978)
  • L. Floru et al.

    The problem of post-psychotic schizophrenic depressions and their pharmacological induction

    Int. Pharmacopsychiatry

    (1975)
  • J.D. Frank

    Persuasion and Healing

    (1973)
  • J. Galdi et al.

    Genetic factors in the response to neuroleptics in schizophrenia: A pharmacogenetic study

    Psychol. Med.

    (1981)
  • R.H. Gerner et al.

    A dopamine mechanism in mania

    Am. J. Psychiatry

    (1976)
  • M. Hamilton

    A rating scale for depression

    J. Neurol. Neurosurg. Psychiatry

    (1960)
  • S.R. Hirsch

    Depression ‘revealed’ in schizophrenia

    Br. J. Psychiatry

    (1982)
  • G.E. Hogarty et al.

    Fluphenazine and social therapy in the aftercare of schizophrenic patients: Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride

    Arch. Gen. Psychiatry

    (1979)
  • D.A.W. Johnson

    Studies of depressive symptoms in schizophrenia

    Br. J. Psychiatry

    (1981)
  • D.A.W. Johnson

    Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia

    J. Clin. Psychiatry

    (1984)
  • D.A.W. Johnson et al.

    A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia

    Acta Psychiatr. Scand.

    (1975)
  • A. Knights et al.

    ‘Revealed’ depression and drug treatment for schizophrenia

    Arch. Gen. Psychiatry

    (1981)
  • A. Knights et al.

    Depressive and extrapyramidal symptoms and clinical effects: A trial of fluphenazine versus flupenthixol in maintenance of schizophrenia outpatients

    Br. J. Psychiatry

    (1979)
  • T.H. McGlashan et al.

    Post-psychotic depression in schizophrenia

    Arch. Gen. Psychiatry

    (1976)
  • Cited by (10)

    • Suicide and schizophrenia

      2001, Journal of Psychopharmacology
    View all citing articles on Scopus
    View full text